Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin)

American Journal of Cardiology

Volumn 81, Issue 6, 1998, Pages 713-718

  Berger, Peter B ^a   Bell, Malcolm R ^a   Grill, Diane E ^a   Melby, Steve ^a   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; Q WAVE; RASH; STENT; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0032521399     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)01005-9     Document Type: Article

References (18)

1. Fischman DL, Leon M, Bain DS, Schatz RZ, Savage MP, Penn I, Detre K, Veltri Lricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
2. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Columbo A, Goy J-J, Van Den Huevel P, Delcan J, Morel M-A, for the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
3. Cohen DJ, Krumholz HM, Sukin CA, Ho KKL, Siegrist RB, Cleman M, Heuser RR, Brinker JA, Moses JW, Savage MP, Detre K, Leon MB, Baim DS, for the Stent Restenosis Study Investigators. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Circulation 1995;92:2480-2487.
4. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-1688.
5. Goldberg SL, Colombo A, Nakamura S, Almagor M, Maiello L, Tobis JM. The benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz Stents. J Am Coll Cardiol 1994;24:996-1003.
6. Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, Finci L, Tobis JM. Intracoronary ultrasound observations during stent implantation. Circulation 1994;89:2026-2034.
7. Goods CM, Al-Shaibi KF, Yadav SS, Liu MW, Negus BH, Iyer SS, Dean LS, Jain SP, Baxley WA, Parks JM, Sutor RJ, Roubin GS. Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound. Circulation 1996;93:1803-1808.
8. Schömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitsky M, Walter H, Zitzmann-Roth E-M, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-1089.
9. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, Ferraro M, Colombo A. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-222.
10. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Hendrickx G, Suryapranata H, Legand V, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the BENESTENT-II Pilot study. Circulation 1996;93:412-422.
11. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr. Guidelines for Percutaneous Transluminal Coronary Angioplasty: A Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee of Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1988;12:525-545.
12. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193-1202.
13. Itoh A, Hall P, Maiello L, Blengino S, Ferraro M, Martini G, Finci L, Colombo A. Intracoronary stent implantation in native coronary arteries and saphenous vein grafts. A consecutive experience with 6 types of stents without prolonged anticoagulation. Mayo Clin Proc 1997;72:101-111.
14. Harker LA, Bruno JB. Ticlopidine's mechanism of action of human platelets. In: Hass WK, Easton JD, eds. Ticlopidine, Platelets and Vascular Disase. New York: Springer-Verlag, 1993:41-59.
15. Schwartz L, Blew B, Bui S. Intracoronary stent placement for coronary artery disease. Lancet 1997;350:113-114.
16. Faxon DP, on behalf of the Multicenter American Research Trial With Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;2:362-369.
17. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King SB III, Mark DB, Isner JM, Holmes DR Jr, Ellis SG, Lee KL, Keeler GP, Berdan LG, Hinohara T, Califf RM, for the CAVEAT Study Group. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-227.
18. Schuhlen H, Hadamitzky M, Walter H, Ulm K, Schomig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement. Analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Resigmen (ISAR) Trial. Circulation 1997;95:2015-2021.